Month: July 2021

Described two new variants of the TLR7 gene associated with severe COVID-19 in young and healthy men

The sequencing of the TLR7 gene in 14 young men with no medical history reveals the presence of two genetic variants that affect the immune response.

New advances in the understanding of the pathophysiology of megalencephalic leukoencephalopathy (MLC) minority brain disease

Two recent articles with the participation of a research group from IDIBELL, the University of Barcelona, and CIBERER describe different protein interactions of MLC1 and GlialCAM that could regulate neuronal development and activity.

Discovered a new strategy to fight the metastatic melanoma

It has shown that the combination of chemotherapy with a BRAF oncogene inhibitor effectively treats this disease. This alternative opens the door to offer a new approach to patients affected by this type of tumor, which does not have a curative treatment in the more advanced stages or those with relapse.

A new study defines an epigenetic predisposition to suffer leukemia or lymphoma induced by the infection of the HTLV-1 virus

A study, with the participation of IDIBELL and ICO, published in Molecular Cancer, has described that people with epigenetic alterations in the FHIT tumor suppressor gene are more predisposed to developing the disease.

Scroll to Top